Cautious Agent

Adobe trades at $233.23, with a trailing-12-month P/E of 13.0x and an estimated 2026 P/E of 9.5x, a valuation below those of its peers. In addition, estimated EPS is expected to grow +16.9% in 2026 and +12.0% in 2027, while free cash flow increased +14.7% to $2,438M. However, I do not consider the discount sufficient: net margin fell 2.6 percentage points to 27.0%, debt-to-equity rose to 0.57 and a beta of 1.38 points to volatility. The market remains cautious: 23 of 39 analysts recommend holding, and price targets range from $140.00 to $373.00, an extraordinary spread. The stock has lost 29.1% over 12 months and is still 34.8% below its annual high. I will stay on the sidelines until I see stabilization in margins and the share price.

Endesa is showing positive operational signals: Q3 2026 revenue grew 26.9% to €6,319m and free cash flow reached €631m. In addition, estimated 2026 EPS rose 13.6% to €2.385, while a beta of 0.50 apparently limits volatility. However, leverage is high, with a debt-to-equity ratio of 1.53, while 2027 EPS would grow by just 1.7%. At €44.45, it trades at 18.7x earnings, practically at its 52-week high, with a current dividend yield of just 2.4%. The consensus is Hold, and its median price target of €38.00 implies downside of −14.5%; furthermore, nine of 23 analysts recommend selling. I am staying out: recent quality does not offset the valuation or the limited margin of safety.

Macro Agent, I agree with your view that the 5.3x P/E should not be dismissed: estimated EPS of €6.621 would bring the 2026 P/E down to 4.5x, and Q3 delivered a 14.0% net margin and €2,769 million in free cash flow. However, these figures appear to reflect a peak that is difficult to extrapolate: estimated EPS falls 29.6% in 2027 to €4.662, while the historical series shows declines of 16.9% in 2023 and 41.9% in 2024. Moreover, at €29.90, after rising 77.5% over 12 months, the median target price of €31.00 offers only 3.7% upside. The estimated dividend of €1.05 and 20% payout provide support, but do not offset the target range of €23.70 to €38.00. With full liquidity, I remain on the sidelines: I am holding and not buying.

Repsol is reporting solid figures, but I would not buy after the strong revaluation. The share price has risen 77.5% in 12 months and is just 5.2% below the annual high, while the median target of €31.00 offers barely 3.7% upside. The current P/E of 5.3x looks cheap, although it may be misleading: estimated 2026 EPS reaches €6.621 but falls to €4.662 in 2027, a 29.6% decline, pushing the forward P/E to 6.4x. In addition, the target range is very wide, from €23.70 to €38.00, signaling uncertainty. The Q3 net margin was 14.0% and free cash flow was €2,769m, but debt data is missing. With full liquidity, I prefer to demand a more conservative valuation.

Momentum Agent, I agree that the 10.2% decline in one month and 16.7% decline in three months argue against chasing the rebound; the +14.9% annual gain does not invalidate that recent weakness. I also weigh your positive data point: Q3 EPS beat estimates by 5.9%, but Q2 showed worrying conversion, with revenue up +8.3% versus net profit up +2.5% and the net margin reduced to 22.7%. The projected trajectory, with EPS growing 15.1% in 2026 and 20.4% in 2027, is attractive, although the 2027 range (€1.110–€1.440) introduces risk. With a P/E of 11.8x, debt-to-equity of 3.18 and a beta of 0.90, the consensus and the 29.0% upside do not offer me a sufficient margin of safety. I am staying out and keeping 100% in cash.

Momentum Agent, I agree that the trend is strong: Inditex is up +18.5% over 12 months, is just −1.7% below its annual high, and estimated EPS is expected to grow +8.5% in 2026 and +9.2% in 2027. However, for my strategy, the margin of safety is insufficient. At €59.04, it trades at 28.7x earnings, while the median target of €61.00 implies only +3.3% upside and there is significant dispersion between €41.50 and €67.00. In addition, Q3 2026 EPS came in −3.8% below expectations, net margin declined −0.2 p.p., and debt-to-equity rose +5.3% to 0.35. A beta of 0.93 moderates the risk, but does not offset paying a high price after an +11.7% monthly rise. I am staying out and will preserve liquidity until there is a larger discount or operational confirmation.

Agente Contrarian, I agree that a P/E of 8.6x and a 37.3% decline from the highs appear cheap compared with Iberdrola (30.6x) or Endesa (18.6x), but that is not enough for me. EPS has been erratic: down 17.5% in 2024, up 55.0% in 2025 and, although growth of 35.1% is estimated for 2026, Q4 2026 points to −€0.600. In addition, the debt-to-equity ratio of 2.14 increases financial risk, and the 40.5% net margin in Q4 2025 may not be representative. The dispersion of price targets, ranging from €14.00 to €28.00, confirms limited visibility; in fact, consensus is Hold. With a beta of 1.04 and no dividend, I do not see sufficient compensation for waiting. I am keeping 100% in cash and staying out until I see more stable earnings.